# Curcuma xanthorrhiza

**Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/curcuma-xanthorrhiza
**Data Source:** Hermetica Superfoods Ingredient Encyclopedia
**Updated:** 2026-03-19
**Evidence Score:** 6 / 10
**Category:** Southeast Asian
**Also Known As:** Curcuma xanthorrhiza, Javanese turmeric, temulawak, kunyit putih, temu lawak, Java ginger, white turmeric

## Overview

Curcuma xanthorrhiza (Javanese turmeric) contains xanthorrhizol as its primary bioactive compound, which may support cholesterol management and provide [antiviral](/ingredients/condition/immune-support) effects. This traditional Jamu ingredient works through [anti-inflammatory](/ingredients/condition/inflammation) and lipid-modulating mechanisms in the body.

## Health Benefits

• May support healthy cholesterol levels (one human study showed efficacy in reducing blood cholesterol in hypercholesterolemic patients, though specific details unavailable)
• Potential [antiviral](/ingredients/condition/immune-support) properties (in vitro studies show activity against SARS-CoV-2 at IC50 125 μg/mL, requires human validation)
• Possible liver protective effects (animal studies demonstrate [hepatoprotective](/ingredients/condition/detox) activity against CCl4-induced damage)
• May inhibit cancer metastasis (mouse studies show xanthorrhizol downregulates [COX-2](/ingredients/condition/inflammation) and MMP-9 pathways)
• Could help prevent muscle atrophy (animal studies show mitigation of cancer-induced muscle wasting)

## Mechanism of Action

Curcuma xanthorrhiza's primary compound xanthorrhizol appears to modulate cholesterol [metabolism](/ingredients/condition/weight-management) through hepatic enzyme regulation, though specific pathways require further elucidation. The [antiviral](/ingredients/condition/immune-support) activity against SARS-CoV-2 demonstrates viral inhibition at cellular level with IC50 values of 125 μg/mL in laboratory studies. Additional curcuminoids present may contribute to [anti-inflammatory](/ingredients/condition/inflammation) effects through COX and LOX pathway inhibition.

## Clinical Summary

Limited human clinical evidence exists for Curcuma xanthorrhiza, with one study demonstrating cholesterol-lowering effects in hypercholesterolemic patients, though specific sample sizes and quantified outcomes are not publicly available. In vitro [antiviral](/ingredients/condition/immune-support) studies show promising activity against SARS-CoV-2 at 125 μg/mL concentrations, but human validation studies are absent. The current evidence base is preliminary and requires robust randomized controlled trials to establish clinical efficacy. Traditional use in Jamu medicine provides historical context but lacks systematic clinical documentation.

## Nutritional Profile

Curcuma xanthorrhiza (Javanese turmeric) rhizome contains moderate carbohydrate content (approximately 60-70% dry weight as starch), with low protein (~5-8% dry weight) and minimal fat (~3-5% dry weight). Dietary fiber is present at approximately 10-15% dry weight. Key bioactive compounds include xanthorrhizol (a sesquiterpenoid bisabolane-type compound), the primary marker compound found at approximately 0.8-3.0% in essential oil, and curcuminoids (curcumin, demethoxycurcumin, bisdemethoxycurcumin) at lower concentrations (~0.5-1.5% dry weight) compared to Curcuma longa. Essential oil content ranges from 3-12% dry weight depending on origin and processing. Minerals present include potassium (~1,200-1,500 mg/100g dry weight), calcium (~200-400 mg/100g dry weight), magnesium (~150-250 mg/100g dry weight), and iron (~10-20 mg/100g dry weight). Vitamin C is present at modest levels (~15-30 mg/100g fresh weight). Xanthorrhizol exhibits higher bioavailability relative to curcumin due to its lipophilic sesquiterpenoid structure; however, curcuminoid bioavailability remains limited without lipid or piperine co-administration. Phenolic compounds including flavonoids contribute to [antioxidant](/ingredients/condition/antioxidant) capacity (DPPH radical scavenging activity documented in vitro). Data on precise micronutrient concentrations in fresh versus dried rhizome form is limited in peer-reviewed literature.

## Dosage & Preparation

No standardized human dosages are established from clinical trials. Preclinical studies used ethanol extracts at 2.5-125 μg/mL in vitro and xanthorrhizol at 8-32 μg/mL. The cholesterol study used an oral curcuminoid fraction, but exact dosage was not specified. Consult a healthcare provider before starting any new supplement.

## Safety & Drug Interactions

Safety data for Curcuma xanthorrhiza is limited, though it appears generally well-tolerated based on traditional use patterns in Indonesian medicine. Potential interactions with anticoagulant medications may occur due to curcuminoid content, similar to other Curcuma species. Gastrointestinal upset and allergic reactions are possible, particularly in sensitive individuals. Pregnancy and breastfeeding safety has not been established through clinical studies, warranting caution during these periods.

## Scientific Research

Human clinical evidence is limited to two small trials: one RCT (PMID: 29445400) found no significant effects on SLE disease markers when combined with vitamin D3, while another study (PMID: 27365981) reported cholesterol-lowering effects in hypercholesterolemic patients. Most evidence comes from preclinical in vitro and animal studies examining [antiviral](/ingredients/condition/immune-support), anticancer, and [hepatoprotective](/ingredients/condition/detox) effects.

## Historical & Cultural Context

In Indonesian traditional medicine (Jamuan), C. xanthorrhiza rhizomes have been used for centuries as a remedy for liver disorders, digestive issues, and general wellness. The herb is traditionally prepared as decoctions or powders from the dried rhizome.

## Synergistic Combinations

Vitamin D3, milk thistle, artichoke extract, dandelion root, alpha-lipoic acid

## Frequently Asked Questions

### What is the difference between Curcuma xanthorrhiza and regular turmeric?

Curcuma xanthorrhiza (Javanese turmeric) contains xanthorrhizol as its primary bioactive compound, while regular turmeric (Curcuma longa) is rich in curcumin. Javanese turmeric has traditionally been used in Indonesian Jamu medicine for different therapeutic purposes than common turmeric.

### How much Curcuma xanthorrhiza should I take for cholesterol?

No standardized dosage has been established for Curcuma xanthorrhiza supplementation, as clinical studies have not provided specific dosing protocols. The cholesterol study mentioned effective results but did not specify exact dosages used. Consult a healthcare provider for personalized dosing recommendations.

### Does Curcuma xanthorrhiza work against COVID-19?

Laboratory studies show Curcuma xanthorrhiza has antiviral activity against SARS-CoV-2 at 125 μg/mL concentrations in cell cultures. However, no human clinical trials have tested its effectiveness against COVID-19, and in vitro results do not guarantee real-world efficacy in humans.

### Can I take Curcuma xanthorrhiza with blood thinners?

Curcuma xanthorrhiza may potentially interact with anticoagulant medications due to its curcuminoid content, similar to other turmeric species. This could theoretically increase bleeding risk when combined with warfarin or other blood thinners. Always consult your healthcare provider before combining with prescription medications.

### Where does Curcuma xanthorrhiza come from originally?

Curcuma xanthorrhiza is native to Indonesia and Malaysia, where it grows naturally in tropical climates. It has been used for centuries in traditional Indonesian Jamu medicine and is also found in other Southeast Asian countries as part of indigenous healing practices.

### Is Curcuma xanthorrhiza safe during pregnancy and breastfeeding?

Limited safety data exists for Curcuma xanthorrhiza use during pregnancy and breastfeeding, so it is generally recommended to avoid supplementation during these periods unless under medical supervision. Traditional use in Southeast Asian cultures does not provide sufficient modern clinical evidence to establish safety thresholds for pregnant or nursing women. Consult a healthcare provider before using this ingredient if you are pregnant, planning pregnancy, or breastfeeding.

### What does clinical research show about Curcuma xanthorrhiza's effectiveness?

Human clinical evidence for Curcuma xanthorrhiza is limited, with one study demonstrating efficacy in reducing blood cholesterol levels in hypercholesterolemic patients, though detailed results are sparse. Most supporting evidence comes from in vitro and animal studies, including hepatoprotective effects and antiviral activity against SARS-CoV-2 in laboratory conditions. Robust, large-scale human clinical trials are needed to confirm efficacy and establish optimal dosing for health benefits.

### Who should consider taking Curcuma xanthorrhiza supplements?

Individuals with elevated cholesterol levels or those seeking liver support may benefit most from Curcuma xanthorrhiza, based on available preliminary evidence. People interested in traditional Southeast Asian herbal practices may also explore this ingredient as part of a broader wellness regimen. However, those with liver disease, taking anticoagulants, or with curcumin sensitivities should consult a healthcare provider before supplementing.

---

*Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com*
*License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*